Peter Jüni to Aged, 80 and over
This is a "connection" page, showing publications Peter Jüni has written about Aged, 80 and over.
Connection Strength
0.056
-
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J. 2019 10 07; 40(38):3143-3153.
Score: 0.006
-
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial. Circulation. 2019 11 19; 140(21):1693-1702.
Score: 0.006
-
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial. Lancet. 2018 09 01; 392(10149):737-746.
Score: 0.005
-
Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes. Int J Cardiol. 2018 Nov 01; 270:7-13.
Score: 0.005
-
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Apr; 55(4):457-464.
Score: 0.005
-
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study. PLoS One. 2017; 12(8):e0182632.
Score: 0.005
-
Rates and predictors of hospital readmission after transcatheter aortic valve implantation. Eur Heart J. 2017 Jul 21; 38(28):2211-2217.
Score: 0.005
-
Effects of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A study of age- and gender-matched cohorts. Int J Cardiol. 2017 Sep 15; 243:150-155.
Score: 0.005
-
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. EuroIntervention. 2017 Apr 07; 12(18):e2170-e2176.
Score: 0.005
-
Factors affecting screening for hepatocellular carcinoma. Ann Hepatol. 2014 Mar-Apr; 13(2):204-10.
Score: 0.004
-
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. EuroIntervention. 2014 Jan 22; 9(9):1076-84.
Score: 0.004